Related Experiment Video
Updated: Jan 20, 2026

Analysis of Hematopoietic Stem Progenitor Cell Metabolism
Published on: November 9, 2019
Fancd2-deficient hematopoietic stem and progenitor cells depend on augmented mitochondrial translation for survival
Srinivas Chatla1, Wei Du2, Andrew F Wilson1
1Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States of America.
Abstract:
Members of the Fanconi anemia (FA) protein family are involved in multiple cellular processes including response to DNA damage and oxidative stress. Here we show that a major FA protein, Fancd2, plays a role in mitochondrial biosynthesis through regulation of mitochondrial translation. Fancd2 interacts with Atad3 and Tufm, which are among the most frequently identified components of the mitochondrial nucleoid complex essential for mitochondrion biosynthesis. Deletion of Fancd2 in mouse hematopoietic stem and progenitor cells (HSPCs) leads to increase in mitochondrial number, and enzyme activity of mitochondrion-encoded respiratory complexes. Fancd2 deficiency increases mitochondrial protein synthesis and induces mitonuclear protein imbalance. Furthermore, Fancd2-deficient HSPCs show increased mitochondrial respiration and mitochondrial reactive oxygen species. By using a cell-free assay with mitochondria isolated from WT and Fancd2-KO HSPCs, we demonstrate that the increased mitochondrial protein synthesis observed in Fancd2-KO HSPCs was directly linked to augmented mitochondrial translation. Finally, Fancd2-deficient HSPCs are selectively sensitive to mitochondrial translation inhibition and depend on augmented mitochondrial translation for survival and proliferation. Collectively, these results suggest that Fancd2 restricts mitochondrial activity through regulation of mitochondrial translation, and that augmented mitochondrial translation and mitochondrial respiration may contribute to HSC defect and bone marrow failure in FA.
Insights
Fanconi anemia (FA) protein Fancd2 normally restricts mitochondrial activity. Its absence boosts mitochondrial translation and respiration, potentially causing bone marrow failure in FA patients.
Area of Science:
- Mitochondrial biology
- Hematopoiesis
- DNA repair
Background:
- Fanconi anemia (FA) is a rare genetic disorder.
- FA proteins, including Fancd2, are crucial for DNA repair and stress response.
- Mitochondrial dysfunction is implicated in various diseases.
Purpose of the Study:
- To investigate the role of Fancd2 in mitochondrial function.
- To explore the impact of Fancd2 deficiency on mitochondrial biosynthesis and translation.
- To understand the contribution of mitochondrial alterations to FA pathogenesis.
Main Methods:
- Gene deletion of Fancd2 in mouse hematopoietic stem and progenitor cells (HSPCs).
- Analysis of mitochondrial number, enzyme activity, and protein synthesis.
- Cell-free assays to assess mitochondrial translation.
- Assessment of mitochondrial respiration and reactive oxygen species (ROS) production.
Main Results:
- Fancd2 deletion increased mitochondrial number, enzyme activity, and protein synthesis in HSPCs.
- Fancd2 deficiency led to increased mitochondrial respiration and ROS production.
- Augmented mitochondrial translation was directly linked to Fancd2 deficiency.
- Fancd2-deficient HSPCs showed sensitivity to mitochondrial translation inhibition.
Conclusions:
- Fancd2 restricts mitochondrial activity by regulating mitochondrial translation.
- Increased mitochondrial translation and respiration in Fancd2-deficient cells may contribute to HSC defects and bone marrow failure in FA.
- Targeting mitochondrial translation could be a therapeutic strategy for FA.
More Related Videos
07:17Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps
Published on: July 30, 2019
09:44Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
Published on: September 5, 2019
Related Concept Videos
12:20Analysis of Hematopoietic Stem Progenitor Cell Metabolism
07:17Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps
09:44Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
03:05Direct Reprogramming of Hematopoietic Progenitor Cells into Neural Stem Cells
12:04Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
11:16Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells